Back to results
US 2015/0104457 A1Published application
Il-17 antagonist antibodies
AssigneeOrega Biotech
InventorsGilles Alberici, Jeremy Bastid, Armand Bensussan, Nathalie Bonnefoy, Jean-Francois Eliaou
Life of this patent
Estimating the term…
Abstract
The disclosure relates to antibodies against human IL-17 which act as antagonist antagonists of IL-17, and their use in the diagnosis or treatment of IL-17 mediated diseases.
Claims36
An isolated IL-17 antibody which binds, as a major epitope, an epitope consisting of a sequence of the human IL-17A as set forth in SEQ ID NO:
- 8.
A method for producing an antibody that specifically binds IL-17, comprising the steps of:
- culturing a host cell of claim 14, 23 or 24 under conditions suitable for expressing the antibody, and
- recovering the antibody.
Dependencies are inferred from the claim text.